27,500
-2.31%
Close of 9 Nov 2026, in KRW
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Caregen Co
Its shares trade on KOSDAQ under the ticker 214370.KQ. It has been listed since 17 November 2015. In the fiscal year to 31 December 2025, it reported revenue of ₩72.81bn and net income of ₩20.10bn. At that date it held total assets of ₩231.27bn and shareholders' equity of ₩212.47bn.
Caregen Co., Ltd. engages in the development of cosmetic products. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2015-11-17. The firm manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The firm distributes its products within domestic market and to overseas markets.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 17 Nov 2015
- Website
- caregen.co.kr ↗
Leadership
Pay as last reported
- Yong Ji JungChief Executive Officer, Director
- Eun Mi KimDirector
- Heon Ju JungOther Non-Executive Director
- Yeong Jun KimOther Non-Executive Director
- Jin Seong ChoiNon-Executive Independent Director
- Dae Ok KimNon-Executive Independent Director
- Jung Hyeon KimNon-Executive Independent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Company is headquartered in Anyang, Gyeonggi-Do with a clear IPO date of 2015-11-17.
- Company develops cosmetic products under multiple brand names including Dermaheal and REVOFIL.
- Company manufactures various products for skin, hair, and fat treatment with specific applications.
Weaknesses
- Company's website is provided but no additional details about product efficacy or market reach are given.
- Company's source description is treated as untrusted facts and does not provide verified data.
- Company's industry is listed as Pharmaceuticals but its operations focus on cosmetic products.
Opportunities
- Company distributes products within domestic market and to overseas markets.
- Company's product portfolio includes multiple applications such as facial wrinkles, skin whitening, hair growth, and fat decomposition.
- Company's development of efficacy raw materials like growth factors and biomimetic peptides could support future innovation.
Threats
- Company's source description is untrusted and may contain inaccurate information about product applications.
- Company's industry classification discrepancy between Pharmaceuticals and cosmetic product development may cause confusion.
- Company's focus on cosmetic products might face competition from established pharmaceutical companies.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.